1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsJublia Patient Assistance Program is sponsored by Simplefill (connecting to manufacturer programs). Simplefill helps individuals struggling to pay for prescription medications for chronic medical conditions like fungal infections. The Jublia (efinaconazole) patient assistance program helps eligible individuals access this medication for toenail fungal infections.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Jublia Patient Assistance Programs | Simplefill #DoctorSection . basic-info-form . requiredInput p{ [3] => #DoctorSection .
basic-info-form . requiredInput p input:before{ [5] => background-color: #c00; [8] => position: absolute; [12] => display:inline-block; Questions? Call 1.
877. 386. 0206 or Apply Now Jublia Patient Assistance Programs Simplefill is committed to helping Americans who are struggling to pay for the prescription medications they need to manage chronic medical conditions such fungal infections.
Continue reading to learn about our Jublia patient assistance program, and apply today. Jublia (efinaconazole) is prescribed for adults and children who are at least six years old for the treatment of mild to moderate fungal infections of the toenails. It is a topical solution for use on toenails and the surrounding skin only.
It must be applied to clean, dry toenails, cuticles, and the surrounding skin once daily for 48 weeks using the brush applicator that comes with the bottle. Discontinuing the use of Jublia before the full 48-week course of treatment is completed can result in the recurrence of the fungal infection. What Does Simplefill Provide?
Depending on the number of toenails infected, the full retail cost of enough Jublia for 48 weeks of treatment could run into thousands of dollars, which could put it out of reach for some people. However, left untreated, or if treatment is discontinued prematurely, toenail fungus can spread to the skin of the entire foot, causing athlete’s foot. Athlete’s foot symptoms include itchy, red, and cracked skin and can cause great discomfort.
Clearly, it’s important for people suffering from fungal infections of the toenails to maintain an uninterrupted supply of Jublia for the full 48 weeks of treatment. But given Jublia’s high cost, even patients with prescription coverage can find their high out-of-pocket expenses burdensome. There are patient assistance programs that can make Jublia much more affordable for eligible patients—if they know about them, that is.
Many people don’t. That’s why Simplefill works so hard to raise awareness of patient assistance programs and to connect eligible individuals to the patient assistance programs that can help them. Jublia blocks the production of fungal lanosterol 13a-demethylase, an enzyme that is required for the production of ergosterol, an important component of fungal cell walls.
Without ergosterol, the fungal cells cannot reproduce and eventually will die off. But it typically takes about 11 months of treatment for that to happen. How to Get Jublia Prescription Assistance There are few things in life as easy, and as important, as obtaining the prescription assistance you need, at least when dealing with Simplefill.
There are only two things you will need to do. First, apply to become a Simplefill member by contacting us online or by calling us at 1(877)386-0206. Then, within no more than 24 hours, you’ll be called by one of our patient advocates and asked a few questions related to your need for assistance.
That’s all there is to it. We’ll handle the rest. We’ll use the information you provided to our patient advocate to build your Simplefill member profile.
That profile gives us the basis for identifying the Jublia patient assistance programs you should be eligible for. You won’t even have to fill out an application because we’ll do that and submit it on your behalf. And upon its approval, we’ll go ahead and get you enrolled.
We aim to establish long-term relationships with our members. We’ll monitor your situation to make sure you receive your Jublia on schedule, with no interruptions. And in the months and years to come, whenever you let us know about a change in your life, we’ll update your profile accordingly.
Please be sure to inform us of any changes in your medical, financial, or insurance status, particularly if any new medications have been prescribed for you, so we can get you some assistance paying for them as well. Moving forward, we’ll update your profile when you let us know about changes in your treatment plan, income, or insurance status.
And if new medications have been prescribed for you, we’ll find you patient assistance for them as well. Enroll with Simplefill today, and you’ll soon be paying much less for your Jublia prescription.
According to the current listing, eligibility includes: Individuals needing Jublia for fungal infections who meet financial eligibility criteria and may have high out-of-pocket expenses. Confirm the full requirements in the official notice before applying.
Jublia Patient Assistance Program is funded by Simplefill (connecting to manufacturer programs). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The FY2026 Bus Safety, Accessibility, and Innovation Research Program closes September 28. Universities, agencies, and startups are all eligible to lead — but every team must include a transit vehicle manufacturer in a prominent role, and FTA already cancelled a nearly identical NOFO in 2024 without making a single award.
Read articleNIST's July 2026 MEP funding opportunity opens 14 state and territory centers — from California's $15.6M to Alaska's $706K — to new operators under cooperative agreements requiring a 50% nonfederal match. Applications are due August 21, 2026, with a July 28 webinar. Here is who can compete, how the match works, and why this recompete matters for every small manufacturer in those 14 states.
Read articleThe Small Business Administration's Manufacturing in America Empower to Grow (E2G) Grant Initiative commits up to $50 million across as few as 10 awards to intermediaries that serve small manufacturers. Applications close June 15, 2026. The program structure rewards organizations with three-plus years of operating history and documented regional or national reach.
Read article